<?xml version="1.0" encoding="UTF-8"?>
<xml>
<records>
<record>
  <contributors>
    <authors>
      <author>Sesma, Andrea</author>
      <author>Pardo, Julian</author>
      <author>Isla, Dolores</author>
      <author>M. Gálvez, Eva</author>
      <author>Gascón-Ruiz, Marta</author>
      <author>Martínez-Lostao, Luis</author>
      <author>Moratiel, Alba</author>
      <author>Paño-Pardo, J. Ramón</author>
      <author>Quílez, Elisa</author>
      <author>Torres-Ramón, Irene</author>
      <author>Yubero, Alfonso</author>
      <author>Zapata-García, María</author>
      <author>Domingo, María Pilar</author>
      <author>Esteban, Patricia</author>
      <author>Sanz Pamplona, Rebeca</author>
      <author>Lastra, Rodrigo</author>
      <author>Ramírez-Labrada, Ariel</author>
    </authors>
  </contributors>
  <titles>
    <title>Peripheral Blood TCRß Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer</title>
    <secondary-title>Cancers</secondary-title>
  </titles>
  <doi>10.3390/cancers16162798</doi>
  <pages/>
  <volume/>
  <number/>
  <dates>
    <year>2024</year>
    <pub-dates>
      <date>2024</date>
    </pub-dates>
  </dates>
  <abstract/>
</record>

</records>
</xml>